Compare Agilent Technologies Inc (A) vs iShares MBS ETF (MBB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs iShares MBS ETF — how do they compare? Agilent Technologies Inc trades at $128.4 (market cap $37.04B), while iShares MBS ETF trades at $93.71. The key difference: Agilent Technologies Inc pays a 0.78% dividend while iShares MBS ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, iShares MBS ETF nearer its low. Which is the better fit depends on your goals.
| A | MBB | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | — |
52-Week High | $157.20 | $96.91 |
52-Week Low | $110.24 | $92.46 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
MBB (iShares MBS ETF) trades at $93.84, down 0.31% with a bearish technical outlook from moving averages. The ETF shows neutral oscillator signals with RSI at 46.40. Recent institutional activity includes mixed positioning changes, with Comerica Bank reducing its stake by 12.9% while Concurrent Investment Advisors increased its position by 75.4% in Q4 2026. The fund focuses on mortgage-backed securities and has maintained consistent dividend payments.
The outlook for MBB remains cautious due to bearish technical signals and mixed institutional sentiment. Investment opportunities include exposure to the real estate sector with a 4% monthly yield potential, though risks involve interest rate sensitivity and mortgage market volatility. The ETF's defensive characteristics may appeal to income-focused investors seeking diversification.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About iShares MBS ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and TBAs that have economic characteristics that are substantially identical to the economic characteristics of the component securities of the index, and the fund will invest at least 90% of its assets in fixed income securities included in the underlying index that advisor believes will help the fund track the index.
Read more on MBB →
